The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Kinetic Cell-Based Morphological Screening: Prediction of Mechanism of Compound Action and Off-Target Effects
Open accessAbstract
Summary We describe a cell-based kinetic profiling approach using impedance readout for monitoring the effect of small molecule compounds. This non-invasive readout allows continuous sampling of cellular responses to biologically active compounds and the ensuing kinetic profile provides information regarding the temporal interaction of compounds with cells. The utility of this approach was tested by screening a library containing FDA approved drugs, experimental compounds and nature compounds. Compounds with similar activity produced similar impedance-based time-dependent cell response profiles (TCRP). The compounds were clustered based on TCRP similarity. We identified novel mechanisms for existing drugs, confirmed previously reported calcium modulating activity for COX-2 inhibitor, celecoxib and identified an additional mechanism for the experimental compound, monastrol. We also identified and characterized a new anti-mitotic agent. Our findings indicate TCRP approach provides predictive mechanistic information for small molecule compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based Screen
Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W., Schreiber, S. L., & Mitchison, T. J. (1999) · Science · doi:10.1126/science.286.5441.971 · Cited by 1,727
A gene expression database for the molecular pharmacology of cancer
Scherf, U., Ross, D. T., Waltham, M., Smith, L. H., Lee, J. K., Tanabe, L., Kohn, K. W., Reinhold, W. C., Myers, T. G., Andrews, D. T., et al. (2000) · Nature Genetics · doi:10.1038/73439 · Cited by 1,450
An Information-Intensive Approach to the Molecular Pharmacology of Cancer
Weinstein, J. N., Myers, T. G., O'Connor, P. M., Friend, S. H., Fornace, A. J., Kohn, K. W., Fojo, T., Bates, S. E., Rubinstein, L. V., Anderson, N. L., et al. (1997) · Science · doi:10.1126/science.275.5298.343 · Cited by 1,183
A morphological biosensor for mammalian cells
Giaever, I., & Keese, C. R. (1993) · Nature · doi:10.1038/366591a0 · Cited by 770
Multidimensional Drug Profiling By Automated Microscopy
Perlman, Z. E., Slack, M. D., Feng, Y., Mitchison, T. J., Wu, L. F., & Altschuler, S. J. (2004) · Science · doi:10.1126/science.1100709 · Cited by 660
Drug target validation and identification of secondary drug target effects using DNA microarrays
Marton, M. J., DeRisi, J. L., Bennett, H. A., Iyer, V. R., Meyer, M. R., Roberts, C. J., Stoughton, R., Burchard, J., Slade, D., Dai, H., et al. (1998) · Nature Medicine · doi:10.1038/3282 · Cited by 643
Hieronymus, H., Lamb, J., Ross, K. N., Peng, X. P., Clement, C., Rodina, A., Nieto, M., Du, J., Stegmaier, K., Raj, S. M., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.005 · Cited by 624
Monitoring fibroblast behavior in tissue culture with an applied electric field.
Giaever, I., & Keese, C. R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3761 · Cited by 608
Failing the Public Health — Rofecoxib, Merck, and the FDA
Topol, E. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048286 · Cited by 599
Weaver, B. A. A., & Cleveland, D. W. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.011 · Cited by 520
Wei, G., Twomey, D., Lamb, J., Schlis, K., Agarwal, J., Stam, R. W., Opferman, J. T., Sallan, S. E., den Boer, M. L., Pieters, R., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.09.006 · Cited by 509
Discovering potent and selective reversible inhibitors of enzymes in complex proteomes
Leung, D., Hardouin, C., Boger, D. L., & Cravatt, B. F. (2003) · Nature Biotechnology · doi:10.1038/nbt826 · Cited by 385
Application of Real-Time Cell Electronic Sensing (RT-CES) Technology to Cell-Based Assays
Solly, K., Wang, X., Xu, X., Strulovici, B., & Zheng, W. (2004) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2004.2.363 · Cited by 381
Self-citationIntegrating high-content screening and ligand-target prediction to identify mechanism of action
Young, D. W., Bender, A., Hoyt, J., McWhinnie, E., Chirn, G.-W., Tao, C. Y., Tallarico, J. A., Labow, M., Jenkins, J. L., Mitchison, T. J., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.2007.53 · Cited by 345
Identifying off-target effects and hidden phenotypes of drugs in human cells
MacDonald, M. L., Lamerdin, J., Owens, S., Keon, B. H., Bilter, G. K., Shang, Z., Huang, Z., Yu, H., Dias, J., Minami, T., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio790 · Cited by 293
Kocisko, D. A., Baron, G. S., Rubenstein, R., Chen, J., Kuizon, S., & Caughey, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10288-10294.2003 · Cited by 231
DeBonis, S., Skoufias, D. A., Lebeau, L., Lopez, R., Robin, G., Margolis, R. L., Wade, R. H., & Kozielski, F. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1079.3.9 · Cited by 215
López-Lázaro, M., Pastor, N., Azrak, S. S., Ayuso, M. J., Austin, C. A., & Cortés, F. (2005) · Journal of Natural Products · doi:10.1021/np050226l · Cited by 188
Gunther, E. C., Stone, D. J., Gerwien, R. W., Bento, P., & Heyes, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1632587100 · Cited by 182
Dynamic and Label-Free Cell-Based Assays Using the Real-Time Cell Electronic Sensing System
Atienza, J. M., Yu, N., Kirstein, S. L., Xi, B., Wang, X., Xu, X., & Abassi, Y. A. (2006) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2006.4.597 · Cited by 178
Self-citationAbraham, V. C., Towne, D. L., Waring, J. F., Warrior, U., & Burns, D. J. (2008) · SLAS DISCOVERY · doi:10.1177/1087057108318428 · Cited by 153
Kardosh, A., Golden, E. B., Pyrko, P., Uddin, J., Hofman, F. M., Chen, T. C., Louie, S. G., Petasis, N. A., & Schönthal, A. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5555 · Cited by 151
Pyrko, P., Kardosh, A., Liu, Y.-T., Soriano, N., Xiong, W., Chow, R. H.-P., Uddin, J., Petasis, N. A., Mircheff, A. K., Farley, R. A., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0629 · Cited by 138
James, J. S., Murry, D. J., Treston, A. M., Storniolo, A. M., Sledge, G. W., Sidor, C. F., & Miller, K. D. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-9008-5 · Cited by 128
Rosiglitazone and cardiotoxicity –weighing the evidence
Nathan, D. M. (2007) · New England Journal of Medicine · doi:10.1056/nejme078117 · Cited by 126 · cited 1×
“This problem was recently highlighted by issuance of a safety alert by the FDA for the diabetes drug Avandia and also the withdrawal of the pain medication Vioxx from the market (Nathan, 2007; Slordal and Spigset, 2006; Topol, 2004).”
BackgroundBielawski, K., Winnicka, K., & Bielawska, A. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1493 · Cited by 126
Heart Failure Induced by Non-Cardiac Drugs
rdal, L. S., & Spigset, O. (2006) · Drug Safety · doi:10.2165/00002018-200629070-00003 · Cited by 124
Calleja, C., Pascussi, J., Mani, J. C., Maurel, P., & Vilarem, M. (1998) · Nature Medicine · doi:10.1038/nm0198-092 · Cited by 117
Involvement of Intracellular Ca2+ Levels in Nonsteroidal Anti-inflammatory Drug-induced Apoptosis
Tanaka, K., Tomisato, W., Hoshino, T., Ishihara, T., Namba, T., Aburaya, M., Katsu, T., Suzuki, K., Tsutsumi, S., & Mizushima, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502956200 · Cited by 105
Dihydropyridine Calcium Channel Antagonists in the Management of Hypertension
Epstein, B. J., Vogel, K., & Palmer, B. F. (2007) · Drugs · doi:10.2165/00003495-200767090-00005 · Cited by 105
Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells.
Zhang, W., Couldwell, W. T., Song, H., Takano, T., Lin, J. H.-C., & Nedergaard, M. (2000) · PubMed · Cited by 97
Self-citationNovel 2-methoxyestradiol analogues with antitumor activity.
Tinley, T. L., Leal, R. M., Randall‐Hlubek, D. A., Cessac, J. W., Wilkens, L. R., Rao, P. N., & Mooberry, S. L. (2003) · PubMed · Cited by 96
Greenberg, D. A., Carpenter, C. L., & Messing, R. O. (1987) · PubMed · Cited by 77
Cellular Phenotype Recognition for High-Content RNA Interference Genome-Wide Screening
Wang, J., Zhou, X., Bradley, P. L., Chang, S., Perrimon, N., & Wong, S. T. C. (2008) · SLAS DISCOVERY · doi:10.1177/1087057107311223 · Cited by 72
Bogatcheva, N. V., Adyshev, D. M., Mambetsariev, B., Moldobaeva, N., & Verin, A. D. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00217.2006 · Cited by 60
Aizu-Yokota, E., Ichinoseki, K., & Sato, Y. (1994) · Carcinogenesis · doi:10.1093/carcin/15.9.1875 · Cited by 44
Wu, K., Dupre, E., Kim, H., Tin-U, C., Bissonnette, R. P., Lamph, W. W., & Brown, P. H. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9071-1 · Cited by 42
Cited by
Gerets, H. H. J., Tilmant, K., Gerin, B., Chanteux, H., Depelchin, B. O., Dhalluin, S., & Atienzar, F. A. (2012) · Cell Biology and Toxicology · doi:10.1007/s10565-011-9208-4 · Cited by 698
Target Identification for Small Bioactive Molecules: Finding the Needle in the Haystack
Ziegler, S., Pries, V., Hedberg, C., & Waldmann, H. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208749 · Cited by 466
The xCELLigence System for Real-Time and Label-Free Monitoring of Cell Viability
Ke, N., Wang, X., Xu, X., & Abassi, Y. A. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-108-6_6 · Cited by 411
Self-citationLimame, R., Wouters, A., Pauwels, B., Fransen, E., Peeters, M., Lardon, F., De Wever, O., & Pauwels, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046536 · Cited by 300
Judson, R., Houck, K., Martin, M., Richard, A. M., Knudsen, T. B., Shah, I., Little, S., Wambaugh, J., Woodrow Setzer, R., Kothya, P., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw092 · Cited by 232
Metadata
- Authors
- Abassi, Y. A., Xi, B., Zhang, W., Ye, P., Kirstein, S. L., Gaylord, M. R., Feinstein, S. C., Wang, X., & Xu, X.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 16
- Issue
- 7
- Pages
- 712-723
- ISSN
- 1074-5521 (ISSN-L)
- OpenAlex
- W2011907162
- Cited by
- 254
- References
- 38
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.